Colchicine's Impact on Diabetes and Gout: Insights from NHIS Study
Discover findings from a NHIS study on colchicine's benefits for diabetes and gout patients, impacting health insurance practices and coverage strategies.
Discover findings from a NHIS study on colchicine's benefits for diabetes and gout patients, impacting health insurance practices and coverage strategies.
Discover how Medicare's new drug pricing impacts beneficiaries and the health insurance landscape, with significant savings projected through 2027.
A study reveals increased GLP-1RA usage among Medicare beneficiaries with cancer and diabetes, highlighting the need for inclusive research and equitable access.
CVS Health is enhancing pharmacists' roles in chronic disease management, improving healthcare access and affordability, particularly for Medicare beneficiaries.
PhRMA's lawsuit against the U.S. government challenges CMS's new Medicare drug-pricing model, impacting costs and pharmaceutical innovation. Stay informed!
PhRMA is suing the federal government over a new Medicare drug Pricing program. Understand implications for insurance professionals and the pharmaceutical market.
Allstate's lawsuits reveal alleged pharmacy fraud in New York's no-fault insurance system, raising significant concerns for the insurance industry and patient care.
California's SB 1094 aims to lower healthcare costs with biosimilars, impacting insurance dynamics. Discover potential savings and implications for insurers.
Dompé U.S. Inc. agrees to a $32 million settlement for illegal Medicare co-pay payments, raising critical compliance issues for insurance professionals in the industry.
The Texas House Select Committee discusses rising healthcare costs and strategies to enhance pricing transparency and improve rural healthcare access.